Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Novo escalates Lilly false advertising suit with planned bid to halt comparative ads
Novo Nordisk is escalating its legal battle against Eli Lilly over its GLP-1 drug marketing, notifying a federal court that it plans to seek a preliminary injunction that would stop its obesity riv | The company is targeting Lilly ad campaigns that cite what Novo calls “outdated” clinical trials comparing Lilly’s drugs with Ozempic and Wegovy.
922 words~4 min read
